1.Video-assisted Thoracic Surgery Lobectomy.
The Korean Journal of Thoracic and Cardiovascular Surgery 2011;44(1):1-8
No abstract available.
Thoracic Surgery, Video-Assisted
2.Acute Postpneumonectomy Empyema with Bronchopleural Fistula Treated with Vacuum-assisted Closure Device.
The Korean Journal of Thoracic and Cardiovascular Surgery 2012;45(4):260-262
Postpneumonectomy empyema is a life-threatening complication, which is often related with a bronchopleural fistula. After surgical repair of fistula, sterilization of infected pleural cavity is important and usually carried out by long-term cyclic irrigation. We report a case in which vacuum-assisted closure device was successfully applied to sterilize the pleural cavity and obliterate bronchopleural fistula.
Bronchial Fistula
;
Empyema
;
Fistula
;
Negative-Pressure Wound Therapy
;
Pleural Cavity
;
Pneumonectomy
;
Sterilization
3.Result of Surgical Resection for Pulmonary Metastasis from Urothelial Carcinoma.
Woo Sik HAN ; Kwhanmien KIM ; Joon Suk PARK
The Korean Journal of Thoracic and Cardiovascular Surgery 2012;45(4):242-245
BACKGROUND: Treatment of pulmonary metastasis from urothelial cell carcinoma has been mostly palliative chemotherapy and the role of pulmonary metastasectomy has not been investigated much. MATERIALS AND METHODS: This study is a retrospective interim review of pulmonary metastasectomy from urothelial carcinoma at single institution between 1998 and 2010. Overall 16 patients underwent pulmonary metastasectomies. RESULTS: There was no postoperative complication or hospital mortality. Mean hospital stay was 6 days. Overall and disease-free 5-year survival were 65.3% and 37.5%, respectively. CONCLUSION: In selected patients with pulmonary metastasis from urothelial carcinoma, surgical treatment is feasible and could contribute to long-term survival in selected patients.
Hospital Mortality
;
Humans
;
Length of Stay
;
Lung Neoplasms
;
Metastasectomy
;
Neoplasm Metastasis
;
Postoperative Complications
;
Retrospective Studies
4.Primary Acinic Cell Carcinoma of the Lung: A Case Report.
Junhun CHO ; Taeeun KIM ; Joungho HAN ; Kwhanmien KIM ; Tae Sung KIM
Journal of Lung Cancer 2010;9(1):20-23
Primary acinic cell carcinoma (ACC) of the lung is very rare and this tumor is thought to arise from pluripotent cells of the submucosal glands of the tracheobronchial tree. We report here on a case of primary ACC of the lung in a 68-year-old man who had a solitary pulmonary nodule in the left lower lobe. The patient was symptomless and the lesion was found on a chest X-ray taken during a regular health checkup. The video assisted thoracoscopic surgery wedge resection revealed an ovoid yellow tan solid mass that was 1.8 cm at the largest diameter. Microscopically, the neoplastic cells grew in solid sheets of round cells with eccentric nuclei and abundant basophilic granular cytoplasm. There were no mitotic figures or areas of pleomorphic or anaplastic cells. Immunohistochemical staining for cytokeratin (AE1/AE3) was positive, but the staining for chromogranin A and CD56 was negative. Ultrastructural examination revealed polyhedral cells with many zymogen granules of varying electron density. The patient is well 4 months postoperatively.
Acinar Cells
;
Aged
;
Basophils
;
Carcinoma, Acinar Cell
;
Chromogranin A
;
Cytoplasm
;
Electrons
;
Humans
;
Keratins
;
Lung
;
Lung Neoplasms
;
Secretory Vesicles
;
Solitary Pulmonary Nodule
;
Thoracic Surgery, Video-Assisted
;
Thorax
;
Triacetoneamine-N-Oxyl
5.Limited Cytotoxic Effect of Adenoviral-mediated p53 Gene Transfer in Variable Non-small Cell Lung Cancer (NSCLC) Cell Lines.
Jhingook KIM ; Sook Hyun LEE ; Eun Sung HWANG ; Jong Sik KIM ; Kwhanmien KIM ; Je Ho LEE
Journal of the Korean Cancer Association 1997;29(4):565-575
PURPOSE: Cancer gene therapeutic strategy using p53 tumor suppresser gene have been suggested to be effective in many solid tumors including non-small cell lung cancer (NSCLC). To test generalized applicability, we tested a number of non-small cell lung cancer cell lines for their sensitivity to adenoviral-mediated wild-type p53 gene transfer. MATERIALS AND METHOD: Replication-incompetent recombinant adenovirus encoding wild- type p53 (Avp53) under the control of the human cytomegalovirus (CMV) promoter was constructed and the cytotoxic effectiveness was evaluated in various NSCLC cell lines. Because 20 moi (multiplicity of infection; number of active virus particle/cell number) of Avp53 showed highly-effective cytotoxicity in p53-deleted cell lines (NCI-H1299, and NCI-H358), same amount was used for other cell lines. RESULTS: Variable degree of cytotoxicity were observed in cell line with p53 mutation, but almost no effect were observed in those with will-type p53. Neither the infectivity of adenovirus, which was observed by x-gal stain after adenoviral mediated lac Z gene, nor the expression of p53 protein in infected cell, which was observed by western blot, was not the useful marker to expect the cytotoxic effect of Avp53. However, in responsive cell lines with Avp53, prominent expression of p21 protein, which was observed by western blot, was noticed. CONCLUSION: In conclusion, adenoviral-mediated wild-type p53 transfer may not be applicable to every patient with non-small cell lung cancer, especially when the tumor has wild-type p53 gene. Better method to predict the effectiveness before application and strategy to widen the applicable extent is needed.
Adenoviridae
;
Blotting, Western
;
Carcinoma, Non-Small-Cell Lung*
;
Cell Line*
;
Cytomegalovirus
;
Genes, Neoplasm
;
Genes, p53*
;
Humans
6.Metaplastic Thymoma: Report of 4 Cases.
Guhyun KANG ; Nara YOON ; Joungho HAN ; Young Eun KIM ; Tae Sung KIM ; Kwhanmien KIM
Korean Journal of Pathology 2012;46(1):92-95
Metaplastic thymoma (MT), accepted in the World Health Organization 2004 scheme, is a circumscribed tumor of the thymus exhibiting biphasic morphology. We herein describe the clinicopathologic features of four MTs and the differential diagnoses of this unusual tumor. There were three women and one man with mean age of 49.5 years. The patients were found to have mediastinal masses, and underwent surgical excision. One exhibited symptoms of myasthenia gravis, and the serum titer for anti-acetylcholine receptor antibody was positive. Grossly, the tumors were encapsulated, and showed vaguely multinodular, solid, tan-white to yellow cut surfaces. Histologically, they comprised epithelial islands intertwining with bundles of delicate spindle cells. The patients remained well after surgical excision at 5-55 months. Because of the distinctive histological appearance and benign clinical course, MT should be distinguished from other more aggressive mediastinal neoplasms displaying biphasic feature.
Carcinosarcoma
;
Diagnosis, Differential
;
Female
;
Humans
;
Islands
;
Mediastinal Neoplasms
;
Metaplasia
;
Myasthenia Gravis
;
Thymoma
;
Thymus Gland
;
World Health Organization
7.Surgery for Primary Pulmonary Liposarcoma.
Su Wan KIM ; Young Mog SHIM ; Jhingook KIM ; Kwhanmien KIM ; Yong Soo CHOI ; Geung Hwan AHN
The Korean Journal of Thoracic and Cardiovascular Surgery 2004;37(11):942-945
Primary pulmonary liposarcoma is extremely rare disease. It has poor prognosis with early multiple metastases and frequent local recurrences. Surgery is the choice of treatment for liposarcoma. Incomplete resection would result in rapid and aggressive growing of the tumor. We report a case of primary pulmonary liposarcoma which was successfully treated with complete resection without local recurrence and distant metastasis for 10 months.
Liposarcoma*
;
Lung Neoplasms
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local
;
Prognosis
;
Rare Diseases
;
Recurrence
8.The Recurrence and Survival after Complete Resection of Esophageal Cancer.
Hyoung Soo KIM ; Jeong Woo YOO ; Kwhanmien KIM ; Young Mog SHIM
The Korean Journal of Thoracic and Cardiovascular Surgery 2003;36(6):411-417
BACKGROUND: Esophageal cancer is an aggressive disease with a poor prognosis. Recently, neoadjuvant therapy has been used in an attempt to increase the long term survival but has not been shown as a clear advantage. We reviewed the recurrence and survival after complete resection of esophageal cancer without neoadjuvant therapy. MATERIAL AND METHOD: From December 1994 to December 2001, 182 consecutive patients who underwent intrathoracic esophagectomy, transthoracic esophagogastrostomy and two-field lymph node dissection for esophageal cancer without neoadjuvant therapy were studied retrospectively. RESULT: There were 167 men and 15 women. The median age was 65 years (range, 40 to 90 years). The tumor was located in the upper third part of the esophagus in 7 patients (3.8%), middle third in 86 (47.3%), and lower third in 89 (48.9%). The postsurgical stage were as follows: stage 0 in 2 patients (1.1%), stage I in 32 (17.6%), stage IIA in 47 (25.8%), stage IIB in 25 (13.7%), stage III in 54 (29.7%), stage IVA in 10 (5.5%), and stage IVB in 12 (6.6%). The in-hospital mortality rate was 3.8% (7 patients) and complications occurred in 65 patients (35%). Follow-up was complete in 95.6%. The recurrence occurred in 56 patients (30.8%) and the overall 5-year disease free rate was 55%. The overall 5-year survival rate was 57%; it was 80% for patients in stage I, 65% in stage IIA, 58% in stage IIB, 48% in stage III, and 40% in stage IVB. The overall 5-year survival rate of patients with postoperative adjuvant therapy was 59% compared to 34% in patients without postoperative adjuvant therapy (p <0.05). CONCLUSION: The most effective therapy for esophageal cancer may be complete resection. More aggressive surgical therapy and adjuvant therapy may improve the long-term survival, even for advanced stage esophageal cancer.
Esophageal Neoplasms*
;
Esophagectomy
;
Esophagus
;
Female
;
Follow-Up Studies
;
Hospital Mortality
;
Humans
;
Lymph Node Excision
;
Male
;
Neoadjuvant Therapy
;
Prognosis
;
Recurrence*
;
Retrospective Studies
;
Survival Rate
9.The Toxicity of Cisplatin Administered by Isolated Lung Perfusion in Dogs.
Ho Seok I ; Kwhanmien KIM ; Jhingook KIM ; Young Mog SHIM ; Jungho HAN ; Sung Sae HAN
Journal of the Korean Cancer Association 2000;32(6):1122-1132
PURPOSE: This research was designed to evaluate the chronic effect of isolated lung perfusion (ILP) with cisplatin on dogs. MATERIALS AND METHODS: Fifteen dogs were divided into three groups. Group I was in ILP without cisplatin, group II with 2.5 mg/kg and group III with 5.0 mg/kg of cisplatin for 30 minutes respectively. Serial blood samples were taken before and after ILP for quantitative analysis of serum lactate dehydrogenase (LDH) and blood urea nitrogen/creatinine (BUN/Cr). The specimens from the lung were obtained 2 weeks after ILP. RESULTS: There were no statistic significant differences in LDH concentration according to the time interval among the groups. The LDH concentration peaked at 1 week after ILP and declined thereafter to the pre-ILP concentration. The concentration of BUN/Cr was in normal range. Histologic examination showed no pathologic change. No significant histopathologic differences were found in the pulmonary parenchyme and vasculature among the groups. All of the dogs survived without complication 2 weeks after ILP. CONCLUSION: In ILP with cisplatin of 5.0 mg/kg in normal dog, the toxicity of cisplatin itself was not observed. With further study about the technique of ILP with cisplatin it would be effective to deliver high concentration of cisplatin into the target tissue minimizing lung damage.
Animals
;
Cisplatin*
;
Dogs*
;
Drug-Related Side Effects and Adverse Reactions
;
L-Lactate Dehydrogenase
;
Lung*
;
Perfusion*
;
Reference Values
;
Urea
10.Pattern of Recurrence after Curative Resection of Local (Stage I and II) Non-Small Cell Lung Cancer: Difference According to the Histologic Type.
Yong Soo CHOI ; Young Mog SHIM ; Kwhanmien KIM ; Jhingook KIM
Journal of Korean Medical Science 2004;19(5):674-676
The aim of the present study was to evaluate the pattern of recurrence after complete resection of pathological stage I, II non-small cell lung cancer, especially according to the cell type. We reviewed the clinical records of 525 patients operated on for pathologic stage I and II lung cancer. The histologic type was found to be squamous in 253 and non-squamous in 229 patients. Median follow-up period was 40 months. Recurrences were identified in 173 (36%) of 482 enrolled patients; distant metastasis in 70%, distant and local recurrence in 11%, and local recurrence in 19%. Distant metastasis was more common in non-squamous than in squamous cell carcinoma (p=0.044). Brain metastasis was more frequently identified in non-squamous mthan in squamous cell carcinoma (24.2% vs. 7.3%. p=0.005). Multivariate analyses showed that cell type is the significant risk factor for recurrence-free survival in stage I and stage II non-small cell lung cancer. Recurrence-free survival curves showed that non-squamous cell carcinoma had similar risks during early periods of follow-up and more risks after 2 yr from the operation compared to squamous cell carcinoma. Pathological stage and histologic type significantly influence recurrence-free survival.
Brain Neoplasms/mortality/secondary
;
Carcinoma, Non-Small-Cell Lung/*mortality/*pathology/surgery
;
Carcinoma, Squamous Cell/mortality/pathology/surgery
;
Disease-Free Survival
;
Female
;
Follow-Up Studies
;
Humans
;
Lung Neoplasms/*mortality/*pathology/surgery
;
Male
;
Middle Aged
;
Neoplasm Recurrence, Local/mortality/pathology
;
Neoplasm Staging/*mortality
;
Pneumonectomy
;
Risk Factors
;
Survival Analysis